This comprehensive seven-country report contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during this decade. The report explores business and […]
January 2013 Life Science Industry Research Reports
PharmaPoint: Osteoporosis – Global Drug Forecast and Market Analysis to 2022
Despite its maturity, the osteoporosis market is expected to undergo substantial change between 2012 and 2022. Most importantly, the gold-standard’ bisphosphonates will lose patent protection by end-of-year 2013, flooding the marketplace with less expensive generic versions of these physician-preferred medications. […]
PharmaPoint: Epilepsy – Global Drug Forecast and Market Analysis
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. […]
MediPoint: Cervical Total Disc Replacement – Global Analysis and Market Forecasts
Symptomatic cervical disc disease (SCDD) is a degenerative condition of the spine that, in certain instances, can cause debilitating pain and neurological dysfunction. For the past fifty years, anterior cervical discectomy and fusion (ACDF) was the hallmark surgical intervention for […]
Atripla (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “Atripla (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral […]
Complera (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “Complera (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral […]
Stribild (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “Stribild (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral […]
Quad 2 (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of […]
572-Trii (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “572-Trii (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral […]
Dolutegravir (HIV) – Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, “Dolutegravir (HIV) – Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral […]
Stay In Touch